Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance.

Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract. Shares rise in pre-market.

Despite strong Service and other revenues, PacBio reports soft fourth-quarter 2024 results partly due to lower Revio system shipments.

West Pharmaceutical's overall top line in the fourth quarter of 2024 continues to benefit from revenue growth in its Proprietary Products segment.

Airbnb's fourth-quarter 2024 results reflect strong growth in nights and experiences, and platform enhancements, driving solid performance despite...

CSGP's fourth-quarter 2024 results reflect solid y/y top-line growth and expanding market reach, but rising expenses act as headwinds.

GRMN's fourth-quarter 2024 results reflect solid momentum across Outdoor, Fitness, Aviation, Marine and Auto OEM segments.

Growth in revenues across Financial Services and Emerging Vertical benefits TRU's top line in the fourth quarter of 2024.

Advanced Energy's fourth-quarter results highlight strong Data Center and Semiconductor demand despite headwinds in the Industrial, Medical and...

ZTS stock falls despite better-than-expected fourth-quarter results due to a weak 2025 outlook.